Press releases

(French) ADN tumoral circulant dans le sang : un nouveau biomarqueur du cancer

Press release | 19 Jun 2012 - 16h36 | By INSERM PRESS OFFICE
Cancer

Sorry, this press release is only available in French.

TO CITE THIS POST :
Press release – Inserm press room (French) ADN tumoral circulant dans le sang : un nouveau biomarqueur du cancer Link : https://presse.inserm.fr/en/french-adn-tumoral-circulant-dans-le-sang-un-nouveau-biomarqueur-du-cancer/1831/

Other contents In the same category :

Cancer Voir tout

communi

Improving immunotherapies for blood cancers: real-time exploration in the tumor

Monoclonal antibodies are part of the therapeutic arsenal for eliminating cancer cells. Some make use of the immune system to act and belong to a class of treatment called "immunotherapies." But how do these antibodies function within the tumor? And how can ...
communi

Eliminating Senescent Cells Is Not the Answer to a Long and Healthy Life

Until now considered highly promising in the fight against aging, the therapeutic strategy of eliminating the senescent cells that accumulate in the body is being challenged by the team of Dmitry Bulavin, Inserm researcher at the Institute for Research on Cancer and ...
fermer
fermer
RSS Youtube